Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
BMC Pediatrics|May 20, 2024
Identification of neurological complications in childhood influenza: a random forest modelSuyun Li, Weiqiang Xiao, Huixian Li, et al.
Journal of Molecular Biology|April 13, 2010
Generation of novel long-acting globular adiponectin moleculesHongfei Ge, Yumei Xiong, Bryan Lemon, et al.
The Journal of Biological Chemistry|November 28, 2012
An inhibitory antibody against dipeptidyl peptidase IV improves glucose tolerance in vivoJie Tang, Jiangwen Majeti, Athena Sudom, et al.
Molecular and Cellular Endocrinology|February 14, 2013
Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1Yumei Xiong, Gayathri Swaminath, Qiong Cao, et al.
Plos One|June 18, 2015
Trefoil Factor 3 (TFF3) Is Regulated by Food Intake, Improves Glucose Tolerance and Induces Mucinous MetaplasiaHongfei Ge, Jonitha Gardner, Xiaosu Wu, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2012
Phenylalanine derivatives as GPR142 agonists for the treatment of type II diabetesXiaohui Du, Yong-Jae Kim, Sujen Lai, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
5-Alkyl-2-urea-Substituted Pyridines: Identification of Efficacious Glucokinase Activators with Improved PropertiesTodd J Kohn, Xiaohui Du, SuJen Lai, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Novel Series of Potent Glucokinase Activators Leading to the Discovery of AM-2394Paul J Dransfield, Vatee Pattaropong, Sujen Lai, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 DiabetesNarihiro Toda, Xiaolin Hao, Yasuyuki Ogawa, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Aminopyrazole-Phenylalanine Based GPR142 Agonists: Discovery of Tool Compound and in Vivo Efficacy StudiesMing Yu, Mike Lizarzaburu, Alykhan Motani, et al.
Pageof 4